These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10728517)

  • 1. Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants.
    Tobias JD
    South Med J; 2000 Mar; 93(3):294-6. PubMed ID: 10728517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum caffeine concentrations in preterm neonates.
    Leon AE; Michienzi K; Ma CX; Hutchison AA
    Am J Perinatol; 2007 Jan; 24(1):39-47. PubMed ID: 17195151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronological and clinical characteristics of apnea associated with respiratory syncytial virus infection: a retrospective case series.
    Arms JL; Ortega H; Reid S
    Clin Pediatr (Phila); 2008 Nov; 47(9):953-8. PubMed ID: 18648081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection.
    Korppi M; Hiltunen J
    Pediatr Infect Dis J; 2007 Apr; 26(4):316-8. PubMed ID: 17414394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida.
    Light M; Bauman J; Mavunda K; Malinoski F; Eggleston M
    Pediatr Infect Dis J; 2008 Jun; 27(6):512-8. PubMed ID: 18449062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immune responses to infections in infants with acute life threatening events classified as 'near-miss' sudden infant death syndrome.
    Gleeson M; Clancy RL; Cox AJ; Gulliver SA; Hall ST; Cooper DM
    FEMS Immunol Med Microbiol; 2004 Sep; 42(1):105-18. PubMed ID: 15325403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xanthines in apnea of premature infants. Influence on gastroesophageal reflux].
    Sacré L; Vandenplas Y
    Arch Fr Pediatr; 1987 May; 44(5):383-5. PubMed ID: 3619572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylxanthines in apnea of prematurity.
    Aranda JV; Turmen T
    Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan.
    Kaneko M; Watanabe J; Kuwahara M; Ueno E; Hida M; Kinoshita A; Sone T
    J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
    Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
    Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine for apnea of prematurity.
    Hand IL; Noble LM
    N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
    [No Abstract]   [Full Text] [Related]  

  • 17. Respiratory syncytial virus infection in anesthetized weanling rather than adult rats prolongs the apneic responses to right atrial injection of capsaicin.
    Peng W; Zhuang J; Harrod KS; Xu F
    J Appl Physiol (1985); 2007 Jun; 102(6):2201-6. PubMed ID: 17363622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Respiratory syncytial virus prophylaxis among preterm infants--four seasons' experience].
    Klimek M; Kwinta P; Kruczek P; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):34-8. PubMed ID: 19485253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?
    Geskey JM; Ceneviva GD; Brummel GL; Graff GR; Javier MC
    Clin Ther; 2004 Dec; 26(12):2130-7. PubMed ID: 15823776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.
    Singleton R; Dooley L; Bruden D; Raelson S; Butler JC
    Pediatr Infect Dis J; 2003 Jun; 22(6):540-5. PubMed ID: 12799511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.